Marshall Wace North America’s Benefitfocus, Inc. BNFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-17,586
Closed -$157K 1578
2020
Q1
$157K Sell
17,586
-84,471
-83% -$1.28M ﹤0.01% 934
2019
Q4
$2.24M Buy
+102,057
New +$2.31M 0.01% 553
2019
Q2
Sell
-163,165
Closed -$8.08M 1753
2019
Q1
$8.08M Buy
163,165
+162,172
+16,332% +$8.29M 0.06% 238
2018
Q4
$45K Sell
993
-5,785
-85% -$242K ﹤0.01% 1284
2018
Q3
$274K Sell
6,778
-263,382
-97% -$10.1M ﹤0.01% 806
2018
Q2
$9.08M Buy
+270,160
New +$8.47M 0.05% 354
2017
Q3
Sell
-30,782
Closed -$1.11M 1581
2017
Q2
$1.11M Buy
+30,782
New +$988K 0.01% 915
2013
Q4
$896K Buy
+15,521
New +$756K 0.02% 435

Other funds holding BNFT

Marshall Wace North America's BNFT Position: Q2 2020 in Review

Marshall Wace North America sold out of Benefitfocus, Inc. (BNFT) in Q2 2020, closing a stake of 17,586 shares — an estimated $157K sold.

Marshall Wace North America first reported a position in BNFT in Q4 2013 and held it in 8 quarters. The position peaked at $9.08M in Q2 2018. 114 funds tracked by Wall St. Rank hold BNFT as of Q2 2020.

  • Marshall Wace North America reported no remaining Benefitfocus, Inc. position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace North America sold 17,586 Benefitfocus, Inc. shares in Q2 2020, an estimated $157K.
  • Marshall Wace North America first reported a position in Benefitfocus, Inc. in Q4 2013 and held it in 8 quarters.
  • Marshall Wace North America's Benefitfocus, Inc. position peaked at $9.08M in Q2 2018.
  • 114 funds tracked by Wall St. Rank held Benefitfocus, Inc. as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.